Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma

Autor: Michael Slade, Thomas G. Martin, Nitya Nathwani, Mark A. Fiala, Michael P. Rettig, Feng Gao, Abhinav Deol, Francis K. Buadi, Jonathan L. Kaufman, Craig C. Hofmeister, Tara K. Gregory, Jesus Berdeja, Ajai Chari, Ashley Rosko, Ravi Vij
Rok vydání: 2022
Předmět:
Zdroj: Leukemia. 36:2917-2921
ISSN: 1476-5551
0887-6924
DOI: 10.1038/s41375-022-01691-1
Databáze: OpenAIRE